1. Home
  2. ARCT vs NMCO Comparison

ARCT vs NMCO Comparison

Compare ARCT & NMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • NMCO
  • Stock Information
  • Founded
  • ARCT 2013
  • NMCO 2019
  • Country
  • ARCT United States
  • NMCO United States
  • Employees
  • ARCT N/A
  • NMCO N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • NMCO Finance/Investors Services
  • Sector
  • ARCT Health Care
  • NMCO Finance
  • Exchange
  • ARCT Nasdaq
  • NMCO Nasdaq
  • Market Cap
  • ARCT 320.8M
  • NMCO 594.1M
  • IPO Year
  • ARCT N/A
  • NMCO N/A
  • Fundamental
  • Price
  • ARCT $18.05
  • NMCO $10.88
  • Analyst Decision
  • ARCT Strong Buy
  • NMCO
  • Analyst Count
  • ARCT 10
  • NMCO 0
  • Target Price
  • ARCT $50.88
  • NMCO N/A
  • AVG Volume (30 Days)
  • ARCT 493.8K
  • NMCO 207.6K
  • Earning Date
  • ARCT 11-06-2025
  • NMCO 01-01-0001
  • Dividend Yield
  • ARCT N/A
  • NMCO 5.43%
  • EPS Growth
  • ARCT N/A
  • NMCO N/A
  • EPS
  • ARCT N/A
  • NMCO N/A
  • Revenue
  • ARCT $122,122,000.00
  • NMCO N/A
  • Revenue This Year
  • ARCT N/A
  • NMCO N/A
  • Revenue Next Year
  • ARCT $28.92
  • NMCO N/A
  • P/E Ratio
  • ARCT N/A
  • NMCO N/A
  • Revenue Growth
  • ARCT N/A
  • NMCO N/A
  • 52 Week Low
  • ARCT $8.04
  • NMCO $8.52
  • 52 Week High
  • ARCT $25.88
  • NMCO $11.64
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 58.87
  • NMCO 77.45
  • Support Level
  • ARCT $16.54
  • NMCO $10.26
  • Resistance Level
  • ARCT $19.50
  • NMCO $10.40
  • Average True Range (ATR)
  • ARCT 1.08
  • NMCO 0.09
  • MACD
  • ARCT -0.08
  • NMCO 0.05
  • Stochastic Oscillator
  • ARCT 56.46
  • NMCO 92.65

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About NMCO Nuveen Municipal Credit Opportunities Fund

Nuveen Municipal Credit Opps Fund is a closed-end fund. The fund's objective is to provide a high level of current income exempt from regular U.S. federal income tax and secondarily, total return. It invests in high yielding, low-to medium-quality municipal securities and uses leverage.

Share on Social Networks: